MMPAD Milan Meeting Report

20 European Roadshow - Milano, 29 giugno 2018 RELAZIONE DELL´INCONTRO 9. Cherubini V, Pintaudi B, Rossi MC, et al. Severe hypoglycemia and ketoacidosis over one year in Italian pediatric population with type 1 diabetes mellitus: a multicenter retrospective observational study. Nutr Metab Cardiovasc Dis. 2014;24(5):538- 46. 10. Cherubini V, Skrami E, Ferrito L, et al. High frequency of diabetic ketoacidosis at diagnosis of type 1 diabetes in Italian children: a nationwide longitudinal study, 2004-2013. Sci Rep. 2016;6:38844. 11. Rabbone I et al. Raccomandazioni per la gestione della chetoacidosi diabetica in età pediatrica. Acta Biomed. 2015; 86:5-26 12. Kuppermann N, Ghetti S, Schunk JE, et al. Clinical trial of fluid infusion rates for pediatric diabetic ketoacidosis. N Engl J Med. 2018;378:2275-87. 13. Vanelli M, Chiari C, Ghizzoni L, et al. Effectiveness of a prevention program for diabetic ketoacidosis in children. An 8-year study in schools and private practices. Diabetes Care. 1999;22:7-9. 14. Albanese-O’Neill A, Wu M, Miller KM,et al. Poor adherence to ketone testing in patients with Type 1 Diabetes. Diabetes Care. 2017;40:e38-e39. 15. Ly TT, Maahs DM, Rewers A, et al. ISPAD Clinical Practice Consensus Guidelines 2014. Assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatr Diab. 2014;15 (suppl. 20):180-92. 16. Saggar M, Tsalikian E, Mauras N, et al. Compensatory hyperconnectivity in developing brains of young children with Type 1 Diabetes. Diabetes. 2017;66:754–62. 17. McMahon SK, Ferreira LD, Ratnam N, et al. Glucose requirements to maintain euglycemia after moderate-intensity afternoon exercise in adolescents with type 1 diabetes are increased in a biphasic manner. J Clin Endocrinol Metab. 2007;92:963-968. 18. Miciulis CP, Mascarenhas LP, Boguszewski MC, Campos WD. Physical activity in children with type 1 diabetes. J Pediatr. 2010;86 (4):271-8 19. Raccomandazioni Italiane per la prevenzione e la gestione delle ipoglicemie nel diabete di tipo 1 in età pediatrica. Acta Biomedica. 2018;89:1-34. 20. Marshall SM. Recent advances in diabetic nephropathy. Postgrad Med J. 2004; 80(949):624- 33. 21. Gross J, de Azevedo MJ, Silveiro SP. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care. 2005;28(1):164-76. 22. Har RL, Reich HN, Scholey JW, et al. The urinary cytokine/chemokine signature of renal hyperfiltration in adolescents with type 1 diabetes. PloS One. 2014;13;9(11):e111131. 23. Currie G, McKay G, Delles C. Biomarkers in diabetic nephropathy: Present and future. World J Diabetes. 2014;5(6):763-76. 24. Danne T, Bangstad HJ, Deeb L, et al. ISPAD Clinical Practice Consensus Guidelines 2014. Insulin treatment in children and adolescents with diabetes. Pediatr Diabetes. 2014;15 (Suppl. 20):115–34. 25. Marigliano M, Morandi A, Maschio M, et al. Nutritional education and carbohydrate counting in children with type 1 diabetes treated with continuous subcutaneous insulin infusion: the effects on dietary habits, body composition and glycometabolic control. Acta Diabetol. 2013;50(6):959-64. 26. Forlenza G, Buckingham B, Maahs DM. Progress in Diabetes Technology: Developments in Insulin Pumps, Continuous Glucose Monitors, and Progress towards the Artificial Pancreas. Pediatr Diabetes. 2016;169:13-20. 27. Aleppo G, Ruedy KJ, Riddlesworth TD, et al. REPLACE-BG: A randomized trial comparing continuous glucose monitoring with and without routine blood glucose monitoring in adults with well-controlled Type 1 Diabetes. Diabetes Care. 2017;40(4):538-45. 28. Bekiari E, Kitsios K, Thabit H, et al. Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis. BMJ. 2018;361:k1310.